EMX Systems
UEI: UXT9E61C76L5
• CAGE: 9KMT2
Overview
Awardee Type
Parent
Federal Capability Statement
EMx Biotech's mission is to revolutionize clinical vital sign monitoring through generative AI. Our flagship AI system, xBP, is focused on palliating the risks of invasive blood pressure monitoring for hospitals, clinics, and EMS systems. Today, blood pressure is monitored either through non-invasive cuff-based or invasive arterial methods. Cuff-based methods are susceptible to operator error, causing inaccuracies leading to hypertension misdiagnosis and discordant medication prescriptions. In contrast, arterial monitoring is highly accurate but invasive, expensive, and restricted to specialized settings. Clinicians need a low-cost way to combine the best of arterial monitoring's accurate, real-time, and continuous view of blood pressure with the non-invasive, low-risk accessibility of cuff-based methods.
Keywords
Vital sign monitoring, artificial intelligence, healthcare
Website
Headquarters
Austin, TX
United States
United States
Federal recipient
EMX SYSTEMS LLC
(UEI UXT9E61C76L5, CAGE 9KMT2)
is headquartered in Austin TX.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2023 and
federally registered in
April 2023.
Federal Registration and Certifications
Legal Name
EMX SYSTEMS LLC
UEI
UXT9E61C76L5
CAGE Code
9KMT2
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 21, 2023
Initial Registration
April 11, 2023
Last Registration
April 8, 2026
Registration Activation
April 8, 2026
Registration Expiration
April 6, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
TX
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No